Montagnier, Barre-Sinoussi and zur Hausen Share Nobel

Physiology or medicine prize recognizes work on HIV and human papillomavirus (HPV) linked to cervical cancer--but leaves out Robert Gallo















Share on Tumblr

"We naively thought that the discovery of the virus would allow us to quickly learn more about it, to develop diagnostic tests — which has been done — and to develop treatments, which has also been done to a large extent and, most of all, develop a vaccine that would prevent the global epidemic," she told the newswire.

The work of the other Nobel awardee, Harald zur Hausen, 72, set the stage for the new cervical cancer vaccine.

In 1974 zur Hausen speculated that cervical cancer—the second-most common tumor in women—might be caused by HPV. Nine years later, he identified one strain of the sexually transmitted virus, HPV-16, determining it was found in 53 percent of cervical cancers. Zur Hausen, former scientific director of the German Cancer Research Center in Heidelberg, went on to isolate another strain, HPV-18, which is responsible for another 17 to 23 percent of cases.

Today, the vaccine's manufacturer, Merck, says the vaccine is 95 percent or more effective in preventing tumors in women who receive the three-shot series.

"I'm not prepared for this," zur Hausen told the AP. "We're drinking a little glass of bubbly right now."

Diane Harper, who worked on the cervical cancer vaccine for both Merck and GlaxoSmithKline, which is making its own shots, said she “was delighted this morning to hear the news.”

“It is an honor very much deserved towards our understanding of alternate mechanisms of oncogenesis by virus infections,” Harper said in an e-mail. “His discovery has led to much understanding about HPV, cervical cancer screening and the primary prevention of some cervical cancers.”

Updated at 3:40 p.m. with comment from Gallo, Montagnier, Barre-Sinoussi and zur Hausen.



3 Comments

Add Comment
View
  1. 1. lhpd 09:52 PM 10/6/08

    Again, Robert Gallo should not be surprised that he did not share the prize after the controversy over the HIV virus. His reputation deserved or not did not count in his favor due to his disturbing scientific behavior. It may be an injustice to some, but that's the way the system works. They want Nobel recipients with a clean record.

    Reply | Report Abuse | Link to this
  2. 2. Diwakartejaswi 08:58 AM 10/7/08

    Congratulations Dr Luc Montagnier & Fran篩se Barr魓inoussi,
    It is a late but correct decision by the esteem committee.
    With Best Wishes,
    Dr Diwakar Tejaswi
    MBBS(Gold Medalist); MCH; FCCP; Ph.D.
    HIV Physician & Medical Director
    Regional AIDS Training Center and Network in India (RATNEI)
    International Health Organization
    Patna, Bihar, India
    Mobile: +91-9835078298

    Reply | Report Abuse | Link to this
  3. 3. Lauren 02:06 AM 4/19/10

    too bad Montagnier never actually isolated the virus.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

Montagnier, Barre-Sinoussi and zur Hausen Share Nobel

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X